Biora Therapeutics Home
Activate the mobile navigation

Encapsulating Innovation

Our mission is to reimagine therapeutics and their delivery.

We’re innovating smart capsule technology to deliver the right dose to the right place, safely.

Learn More

Targeted Therapeutics

For people who suffer from gastrointestinal diseases, delivering therapeutics directly to the site of disease could enable safer and more effective drug therapies.

View Pipeline
 
popover=true popoverAnimateThumbnail=true videoFoam=true”> 

Systemic Therapeutics

Our ingestible technology is designed to enable needle-free, systemic delivery of large molecules for better management of chronic diseases.

View Pipeline
 
popover=true popoverAnimateThumbnail=true videoFoam=true”> 

Press Releases

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
Biora Therapeutics Announces $9.75 Million Direct Offering
See More

Publications

A scintigraphic study to evaluate the localization and delivery function of a Drug Delivery System (DDS) device in patients with active ulcerative colitis in fasted state
#Targeted Therapeutics
A scintigraphic study to evaluate the safety, tolerability, and functionality of a Drug Delivery System (DDS) device in healthy volunteers in fasted state
#Targeted Therapeutics
Pilot study to assess pharmacokinetic and pharmacodynamic markers following enema-dosing with adalimumab in patients with active ulcerative colitis
#Targeted Therapeutics
See More